Leblond Julie, Laprise Marie-Hélène, Gaudreau Simon, Grondin Francine, Kisiel Walter, Dubois Claire M
Immunology Division, Faculty of Medicine, Université de Sherbrooke, Sherbrooke, Quebec, Canada J1H 5N4.
Thromb Haemost. 2006 Feb;95(2):243-52. doi: 10.1160/TH05-08-0561.
The cornerstone of hemostasis is the ability of the organism to limit the enzymatic processes involved, thereby avoiding thrombosis. For this, anticoagulant systems in place involve serpins, such as PAI-1 and antithrombin III, which bind to their targeted serine proteases and limit their period of activity. We have previously identified the serine protease furin as a platelet-derived enzyme with an intrinsic role in platelet functions. We now report that furin enzymatic activity decreased rapidly following platelet activation, corresponding with the increase in formation of a high 180 M(r) SDS-stable complex composed of furin and the PI8 serpin. PI8 is shown to be a platelet-derived constituent, synthesized by megakaryocytes and stored in platelets prior to its release. Immunoprecipitation and purification of the PI8-furin complex confirmed their direct interaction and indicates that one of the roles of PI8 is to inhibit furin enzymatic activity. Furthermore, our findings demonstrate the inhibitory capacity of exogenous PI8 in platelet aggregation assays. The finding that PI8 is released by platelets and controls functional responses suggests a role for this serpin in platelet-regulated pathophysiological responses.
止血的基石是机体限制相关酶促过程的能力,从而避免血栓形成。为此,现有的抗凝系统涉及丝氨酸蛋白酶抑制剂,如PAI - 1和抗凝血酶III,它们与靶向丝氨酸蛋白酶结合并限制其活性期。我们之前已鉴定出丝氨酸蛋白酶弗林蛋白酶是一种源自血小板的酶,在血小板功能中具有内在作用。我们现在报告,血小板活化后弗林蛋白酶的酶活性迅速下降,这与由弗林蛋白酶和PI8丝氨酸蛋白酶抑制剂组成的高分子量180 M(r) SDS稳定复合物形成增加相对应。PI8被证明是一种源自血小板的成分,由巨核细胞合成并在释放前储存在血小板中。PI8 - 弗林蛋白酶复合物的免疫沉淀和纯化证实了它们的直接相互作用,并表明PI8的作用之一是抑制弗林蛋白酶的酶活性。此外,我们的研究结果证明了外源性PI8在血小板聚集试验中的抑制能力。PI8由血小板释放并控制功能反应这一发现表明该丝氨酸蛋白酶抑制剂在血小板调节的病理生理反应中发挥作用。